Embecta Corp (EMBC) Price to Earnings Ratio

Corporate emblem and logo of Embecta Corp (EMBC)

The P/E time series for Embecta Corp. (EMBC) illustrates valuation dynamics, with the current figure standing at 4.20. Price stability depends on raw material cost control and adherence to production standards. A leading position in the diabetes consumables segment guarantees consistent demand. Business profitability relies on the mass global distribution of pen injectors and needles.

Embecta Health (EMBC) Price to Earnings Ratio: for the period 04/28/2023 - 11/10/2026

Comprehensive metric breakdowns and analytics for Embecta Inc. (EMBC)

- price and consensus price forecast:
Stock Price embecta.com|EMBC - Price Target Chart
- market capitalization details:
Market Value Embecta Corp.|EMBC - Enterprise Value
- book capitalization information:
Net Assets per Share Embecta|EMBC - Company Net Assets|Market Capitalization to Net Assets embecta.com|EMBC - Company Total Assets
- debt and solvency information:
Debt to Capital Embecta Corp.|EMBC - Long-Term Debt to Capital|Short-Term Debt to Capital Ratio Embecta Health|EMBC - Company Total Debt|Debt to Net Assets Ratio Embecta Corp.|EMBC - Company Long-Term Debt|Company Current Liabilities Embecta|Immediate Liquidity embecta.com
- earnings and market multiples details:
EMBC - Net Profit|Net Profit Forecast Embecta Corp.|EMBC - P/E Multiple|Market Cap to Projected Earnings Embecta Corp|EMBC - PEG Multiple|Enterprise Value to EBITDA Ratio Embecta Corp.|EMBC - Operating profit EBITDA|Net earnings per share (EPS TTM) Embecta|EMBC - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last twelve months embecta.com|EMBC - Net earnings per share growth this year|Expected earnings per share trend next year Embecta Corp.
General company analysis:embecta.com - EMBC
Original product of embecta.com

The P/E ratio determines the investment payback period by relating market value to net income, allowing for an assessment of the asset's overvaluation. By analyzing the price-to-earnings trend, an investor can see the stability of Embecta Corp. (EMBC), whose business model focused on diabetic consumables ensures a predictable cash flow regardless of economic cycles or market volatility.

Analysis of competing companies

P/E Multiple bostonscientific.com|Price to Earnings Ratio Edwards Lifesciences Corporation (EW)|Price to Earnings Ratio RMD (ResMed Inc)|P/E Multiple PODD (OmniPod)|Business Payback Period Zimmer Biomet (ZBH)|COO: Price to Earnings Ratio|Market Cap to Net Income ALGN|GMED: P/E Multiple|Market Cap to Earnings TransMedics Organ Care System (TMDX)|ATEC (ATEC Spine) - P/E Multiple|Price to Earnings Multiple AORT (Artivion Corp)|Price to Earnings Ratio ENOV (Enovis Corporation)|IART (integralife.com) - Company Value to Net Income|Price to Earnings Ratio Establishment Labs Holdings Inc. ESTA|BBNX - Price to Earnings Ratio|Iradimed - P/E Multiple|Market Cap to Earnings Tandem Corp|AXGN: P/E Multiple|Price to Earnings Multiple SIBN|OFIX (Orthofix) - P/E Multiple|Bioventus Inc (BVS) - Business Payback Period|P/E Multiple KIDS|Price to Earnings Ratio Treace Corp TMCI|P/E Multiple SRTA (Strata Critical Medical Inc)|P/E Multiple carlsmed.com CARL|RXST - Price to Earnings Ratio|CLPT: Price to Earnings Ratio|STXS (Stereotaxis Corp) - Price to Earnings Ratio|Neuronetics, Inc - Company Value to Net Income|SGHT (Sight Sciences, Inc.) - P/E Multiple|Market Cap to Earnings orchestrabiomed.com OBIO|Price to Earnings Ratio Anika Therapeutics (ANIK)|InspireMD Inc (NSPR) - Market Cap to Net Income Ratio|Jin Medical - Price to Earnings Ratio|P/E Multiple Vivani Medical Inc VANI|Xtant Medical Inc - P/E Multiple|Business Payback Period n1mtc.com NMTC|modular-medical.com (MODD) - Price to Earnings Ratio|Market Cap to Net Income MYO (Myomo Inc.)|Price to Earnings Ratio Envoy Medical, Inc|Price to Earnings Ratio Vivos Therapeutics Inc (VVOS)|P/E Multiple NVNO|SINT - Market Cap to Earnings|Price to Earnings Ratio Tenon Medical TNON|LFWD: Price to Earnings Multiple|AMIX: Price to Earnings Ratio|INVO Fertility Corp - Market Price to Net Income Ratio|BBLG: P/E Multiple|Market Cap to Earnings axonics.com (AXNX)|Price to Earnings Ratio BIOLASE|Price to Earnings Ratio Dynatronics Corp. (DYNT)|P/E Multiple FNA|Price to Earnings Ratio INVO (invobioscience.com)